What is the efficacy of mulberry component Kuwanon C against COVID-19? MDPIOpenAccess SARSCoV2 COVID19 Mulberry KuwanonC
By Dr. Priyom Bose, Ph.D.Oct 24 2022Reviewed by Aimee Molineux Despite the development of vaccines and therapeutics, the coronavirus disease 2019 pandemic has persisted due to the evolution of severe acute respiratory syndrome coronavirus 2 , the causal agent.
Developments in drug resistance and associated adverse effects have limited the use of certain drugs that were previously used for COVID-19 treatment. For instance, molnupiravir has been associated with reproductive toxicity, and some SARS-CoV-2 variants were resistant to remdesivir and paxlovid. Morus alba L. has been used as a source of traditional medicine due to its hypoglycemic, hypolipidemic, fever-reducing, antiatherogenic, anti-inflammatory, blood pressure-lowering, and antioxidant properties. Interestingly, this plant has also been used in manufacturing vinegar, wines, jams, and juices.
In vitro experiments A recent International Journal of Molecular Sciences study determined the underlying antiviral mechanism of KC associated with the inhibition of SARS-CoV-2.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
A new paper claims SARS-CoV-2 bears signs of genetic engineeringThree unknown scientists claim SARS-CoV-2 has some genetic features that they say would appear if the virus had been stitched together by some form of engineering. It is unclear yet whether this is accurate
Lire la suite »
Research suggests that ORF6 is a major SARS-CoV-2 innate immune antagonistIn a recent study posted to the bioRxiv* server, researchers in the United States demonstrated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) open reading frame 6 (ORF6) protein contributes to viral pathogenesis and modulates the host's immune responses.
Lire la suite »
COVID-19 vaccination during pregnancy protects infants from SARS-CoV-2 infectionIn a recent study under review at the Nature Portfolio journal and currently posted to Research Square* preprint server, researchers evaluated the efficacy of maternal coronavirus disease 2019 (COVID-19) vaccination against infection of infants with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Lire la suite »
Longitudinal cohort study of primary healthcare workers reveals long-lasting SARS-CoV-2 humoral immunity in the absence of vaccinationLongitudinal cohort study of primary healthcare workers reveals long-lasting SARS-CoV-2 humoral immunity in the absence of vaccination UniBarcelona BioMedCentral SARSCoV2 COVID19 Coronavirus HealthcareWorkers HumoralImmunity
Lire la suite »
Fully vaccinated U.S. frontline workers may experience reduced severity, duration, and viral shedding during SARS-CoV-2Fully vaccinated U.S. frontline workers may experience reduced severity, duration, and viral shedding during SARS-CoV-2 JAMA_current JAMANetwork SARSCoV2 COVID19 FrontlineWorker USA Vaccine Vaccination
Lire la suite »
Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cellsBooster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells Antibodies Coronavirus Disease COVID SARSCoV2 Bcell medrxivpreprint
Lire la suite »